Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01260935 · ClinicalTrials.gov registry record · NA
Comparison of Laparoscopic Hill and Laparoscopic Nissen Anti-Reflux Procedures
A NA study of Gastroesophageal Reflux and Gastroesophageal Reflux Disease, sponsored by Swedish Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 121
- Enrollment target
- 1
- Study location
NCT01260935: Completed NA study of Gastroesophageal Reflux and Gastroesophageal Reflux Disease, sponsored by Swedish Medical Center.
NCT01260935 is a NA study of Gastroesophageal Reflux and Gastroesophageal Reflux Disease that has completed, run by Swedish Medical Center. The registered enrollment target is 121 participants, below the 2,883-participant average among 33 other Gastroesophageal Reflux trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01260935, a NA study of Gastroesophageal Reflux and Gastroesophageal Reflux Disease, has completed, sponsored by Swedish Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 121 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare the effects (good and bad) of the Laparoscopic Hill anti-reflux procedure with the Laparoscopic Nissen anti-reflux surgical procedure to see whether one is better than the other.
Primary Outcome
Comparison of these two surgical procedures will be based on pre- and post-surgery quality of life questionnaires, manometry (test that measures muscle pressures in the lower esophagus), pH testing, operative time, early complication rates, and length of hospital stay.
Conditions Studied
Interventions
- PROCEDURE Laparoscopic Hill Repair
- PROCEDURE Laparoscopic Nissen Repair
Study Locations (1)
Washington
- Swedish Medical Center Cancer Institute - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 121 participants |
| Start Date | 2002-11 |
| Est. Completion | 2010-11 |
| Phase | NA |
What the finished NCT01260935 record still lists
NCT01260935 is an interventional study that assigns participants to a tested intervention. The registered 121 participants enrollment target is mid-sized for trials with a published cap, below the 2,883-participant average among 33 other Gastroesophageal Reflux trials with a reported enrollment target (96% lower).
The record links to 4 conditions, with Gastroesophageal Reflux appearing as the primary indexed condition, and to 2 interventions - of which Laparoscopic Hill Repair is the first listed.
NCT01260935 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT01260935 about?
NCT01260935 is a clinical study titled "Comparison of Laparoscopic Hill and Laparoscopic Nissen Anti-Reflux Procedures". The purpose of this study is to compare the effects (good and bad) of the Laparoscopic Hill anti-reflux procedure with the Laparoscopic Nissen anti-reflux surgical procedure to see whether one is better than the other.
What is the current status of trial NCT01260935?
This trial is currently completed. It is a NA study. The enrollment target is 121 participants. The study started on 2002-11. Estimated completion is 2010-11.
What conditions does trial NCT01260935 study?
This clinical trial studies the following conditions: Gastroesophageal Reflux, Gastroesophageal Reflux Disease, GERD, Esophageal Reflux.
What interventions are being tested in trial NCT01260935?
The interventions under investigation include: Laparoscopic Hill Repair (PROCEDURE), Laparoscopic Nissen Repair (PROCEDURE).
Who is sponsoring clinical trial NCT01260935?
This trial is sponsored by Swedish Medical Center, which has 30 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01260935 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gastroesophageal Reflux
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01260935's enrollment target sits among peer trials
121 14th of 33 higher than 20 of 33 other Gastroesophageal Reflux trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Gastroesophageal Reflux trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study of Breath Testing for Small Intestinal Bacterial Overgrowth
RECRUITING · NA
-
Transpyloric Versus Gastric Feeding in Bronchopulmonary Dysplasia
RECRUITING · NA
-
Compassionate Use of Domperidone for Refractory Gastroparesis
RECRUITING · NA
-
External UES Band (Shaker Pressure Band) and GERD
RECRUITING · NA
-
Multi-Site Detection of Barrett's Esophagus in Patients Without Chronic GERD Symptoms
RECRUITING · NA
-
Establishing Pressures at the EGJ During Diaphragmatic Breathing Using High-resolution Esophageal Manometry
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03476681 · 121 participants · Phase 1
Study of NEO-201 in Solid Tumors Expansion Cohorts
- NCT04655118 · 121 participants · Phase 2
Study of TL-895 in Subjects With Myelofibrosis or Indolent Systemic Mastocytosis
- NCT04676802 · 121 participants · Phase 2
Pain Relief After Trapeziectomy: Ibuprofen & Acetaminophen Versus Oxycodone
- NCT05169515 · 121 participants · Phase 1
A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab or Glofitamab in Combination With CC-220 and/or CC-99282 in Participants With B-Cell Non-Hodgkin Lymphoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia